Dr. Sean Callahan, M.D

NPI: 1194811828
Total Payments
$10,162
2024 Payments
$990.16
Companies
45
Transactions
699
Medicare Patients
2,091
Medicare Billing
$287,217

Payment Breakdown by Category

Food & Beverage$10,151 (99.9%)
Education$11.02 (0.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,151 697 99.9%
Education $11.02 2 0.1%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,312 72 $0 (2024)
Novo Nordisk Inc $918.92 76 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $824.27 47 $0 (2024)
ABBVIE INC. $673.41 40 $0 (2024)
Lilly USA, LLC $670.73 52 $0 (2024)
PFIZER INC. $591.23 57 $0 (2024)
Merck Sharp & Dohme LLC $494.88 43 $0 (2022)
Janssen Pharmaceuticals, Inc $476.55 36 $0 (2022)
SANOFI-AVENTIS U.S. LLC $398.94 28 $0 (2020)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $374.64 27 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $990.16 47 AstraZeneca Pharmaceuticals LP ($240.66)
2023 $945.06 57 Novo Nordisk Inc ($146.66)
2022 $1,315 82 ABBVIE INC. ($226.52)
2021 $1,419 98 Boehringer Ingelheim Pharmaceuticals, Inc. ($228.44)
2020 $837.06 54 AstraZeneca Pharmaceuticals LP ($184.34)
2019 $1,530 115 AstraZeneca Pharmaceuticals LP ($260.85)
2018 $1,576 117 AstraZeneca Pharmaceuticals LP ($258.06)
2017 $1,550 129 SANOFI-AVENTIS U.S. LLC ($218.68)

All Payment Transactions

699 individual payment records from CMS Open Payments — Page 1 of 28

Date Company Product Nature Form Amount Type
12/05/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $16.45 General
Category: ANTIBIOTIC
11/26/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.25 General
Category: Respiratory
10/23/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $14.64 General
Category: Obesity
10/10/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.17 General
Category: Respiratory
10/08/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $16.90 General
Category: DIABETES
09/10/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.41 General
Category: NEUROSCIENCE
08/29/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $18.22 General
Category: Respiratory
08/21/2024 Pulmonx Corporation ZEPHYR ENDOBRONCHIAL VALVE (Device) Food and Beverage Cash or cash equivalent $38.00 General
Category: PULMONOLOGY
08/15/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $15.98 General
Category: PSYCHIATRY
08/13/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $26.49 General
Category: Inflammation
07/30/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $20.91 General
Category: ANTILIPEMIC AGENTS
07/23/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.71 General
Category: Cardiovascular and Metabolism
07/18/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.94 General
Category: DIABETES
07/10/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $16.45 General
Category: Diabetes
07/02/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $25.29 General
Category: Oncology
06/25/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $17.09 General
Category: Cardio-renal
06/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $31.25 General
Category: NEUROSCIENCE
06/04/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $22.65 General
Category: Inflammation
05/30/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $17.86 General
Category: Respiratory
05/24/2024 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $14.40 General
Category: Insomnia
05/16/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $17.46 General
Category: Diabetes
05/14/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $18.30 General
Category: Respiratory
04/29/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $21.19 General
Category: PSYCHIATRY
04/27/2024 Lilly USA, LLC JARDIANCE (Drug), ZEPBOUND Food and Beverage In-kind items and services $22.82 General
Category: Diabetes
04/22/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.77 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 518 1,142 $185,114 $79,467
2022 13 506 1,097 $171,726 $77,224
2021 11 473 1,024 $151,172 $67,358
2020 15 594 1,148 $156,167 $63,169
Total Patients
2,091
Total Services
4,411
Medicare Billing
$287,217
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 162 618 $127,926 $50,129 39.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 89 166 $22,576 $9,610 42.6%
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 38 41 $6,970 $5,464 78.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 28 32 $8,896 $4,044 45.5%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 22 39 $3,120 $2,043 65.5%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 24 30 $3,000 $1,978 65.9%
99316 Nursing facility discharge management, more than 30 minutes Facility 2023 20 20 $2,300 $1,803 78.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 13 13 $2,782 $1,494 53.7%
83036 Hemoglobin a1c level Office 2023 42 97 $4,171 $908.20 21.8%
99315 Nursing facility discharge day management, 30 minutes or less Facility 2023 13 13 $949.00 $743.99 78.4%
G0008 Administration of influenza virus vaccine Office 2023 21 21 $834.75 $616.56 73.9%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2023 17 17 $561.00 $371.49 66.2%
G0442 Annual alcohol misuse screening, 5 to 15 minutes Office 2023 12 12 $384.00 $210.00 54.7%
81003 Automated urinalysis test Office 2023 17 23 $644.00 $50.60 7.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 155 567 $115,101 $45,572 39.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 81 145 $19,285 $8,609 44.6%
99306 Initial nursing facility visit per day, typically 45 minutes Facility 2022 48 54 $9,150 $6,861 75.0%
99309 Follow-up nursing facility visit per day, typically 25 minutes Facility 2022 38 82 $8,136 $5,554 68.3%
99316 Nursing facility discharge management, more than 30 minutes Facility 2022 37 38 $4,350 $3,034 69.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 17 20 $5,460 $2,509 46.0%
99310 Follow-up nursing facility visit per day, typically 35 minutes Facility 2022 13 16 $2,310 $1,447 62.6%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 16 27 $2,140 $1,307 61.1%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 11 11 $726.00 $711.48 98.0%
83036 Hemoglobin a1c level Office 2022 34 69 $2,898 $662.09 22.8%
G0008 Administration of influenza virus vaccine Office 2022 22 22 $858.00 $615.47 71.7%

About Dr. Sean Callahan, M.D

Dr. Sean Callahan, M.D is a Family Medicine healthcare provider based in Oak Harbor, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194811828.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Callahan, M.D has received a total of $10,162 in payments from pharmaceutical and medical device companies, with $990.16 received in 2024. These payments were reported across 699 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($10,151).

As a Medicare-enrolled provider, Callahan has provided services to 2,091 Medicare beneficiaries, totaling 4,411 services with total Medicare billing of $287,217. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Oak Harbor, OH
  • Active Since 10/04/2006
  • Last Updated 10/06/2020
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1194811828

Products in Payments

  • JARDIANCE (Drug) $891.71
  • FARXIGA (Drug) $787.10
  • XIFAXAN (Drug) $422.37
  • VRAYLAR (Drug) $394.90
  • JANUVIA (Drug) $366.97
  • CHANTIX (Drug) $329.80
  • Ozempic (Drug) $314.58
  • ELIQUIS (Drug) $313.91
  • XARELTO (Drug) $307.75
  • UBRELVY (Drug) $259.62
  • Kerendia (Drug) $243.84
  • ENTRESTO (Drug) $230.61
  • TOUJEO (Drug) $213.27
  • SYMBICORT (Drug) $210.85
  • Otezla (Drug) $210.31
  • BREZTRI (Drug) $202.86
  • NURTEC ODT (Drug) $194.73
  • TRULICITY (Drug) $176.95
  • INVOKANA (Drug) $162.78
  • EMGALITY (Drug) $162.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Oak Harbor